ClinicalTrials.gg
Active, not recruitingNCT06992544Updated Nov 3, 2026

Trial of Pistachio Consumption in Older Adults

An interventional study of Pistachio-enriched diet and Usual diet in Cognition, Cardiometabolic Risk Factors and Life Satisfaction, sponsored by Brigham and Women's Hospital. Active, not recruiting at 1 site in United States. Open to participants aged 65 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Brigham and Women's Hospital · Not applicable, Interventional, and Prevention

How we know

Updated Nov 3, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
97
Allocation
Randomized
Ages
65 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 91 studies in Personal Satisfaction with a site in United States — 6 open to participants now, 8 under way, none of them phase 3. Personal Satisfaction · United States.

Enrollment
50th of 80
97 · median 117
Started
2025
with 2 others
No phase
65 of 91
4 open now
Registered
85th of 91
by date
Lead sponsor
4 of 91
Brigham and Women's Hospital

Among the 91 studies in Personal Satisfaction with a site in United States, this one is the 50th largest by enrollment of the 80 interventional ones that give a count, is one of 3 that started in 2025, is one of 65 with no phase, and was the 85th registered.

Personal Satisfaction

543 studies on the registry are indexed under Personal Satisfaction; 91 are open to participants now.

Browse Personal Satisfaction studies →

Open to participants now

6 of the 91 studies in Personal Satisfaction with a site in United States are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 38 Personal Satisfaction studies recruiting now, 18 (47%) set no upper age limit and 15 (39%) stop at 75 or younger; 8 take children under 18; 20 take healthy volunteers.

This study: 65 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 91 studies in Personal Satisfaction with a site in United States, or all of them as a file.
02

Study summary

The goal of this study is to evaluate whether a pistachio-enriched diet leads to changes in cognitive function, cardiometabolic risk factors, and life satisfaction in older adults over a 6-month period.

Read the detailed description

In this remote-based, parallel-arm RCT, the investigators will recruit participants from the recently completed COcoa Supplement and Multivitamin Outcomes Study (COSMOS) trial cohort. Eligible COSMOS participants will be invited to participate in the proposed RCT, screened to verify eligibility and willingness to participate, and asked to provide informed consent. Eligible and willing participants will be enrolled and randomized on a rolling basis. Risk factors and Outcome assessments will be conducted at baseline, 3 months and 6 months via the MyCap Mobile Toolbox application, REDCap questionnaires (for life satisfaction, dietary, and other phenotypic assessments), or at a local Quest Diagnostics (for biospecimen collection and return to our biorepository).

03

Conditions studied

  • Cognition
  • Cardiometabolic Risk Factors
  • Life Satisfaction

Browse trials for

Keywords

  • Pistachio
  • Cognition
  • Life satisfaction
  • Older adults
  • Cardiometabolic risk factors
  • Blood pressure
  • Biomarkers
  • Memory
  • Diet
  • Nut intake
04

Who can participate

Ages eligible
65 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Active participant in COSMOS
  2. Current age 65 to 80 years
  3. Does not reside in the states of Arizona, Hawaii, or Wyoming (since Quest Diagnostics does not have locations in these states)

Exclusion criteria

Exclusion Criteria:

  1. Tree nut allergy
  2. Current intake of pistachios, peanuts, walnuts, or other nuts >1 serving/week
  3. Diagnosis of Alzheimer's disease or any other type of dementia
  4. Diagnosis of cancer or CVD (MI, stroke, CABG, PTCA, or stent) within last 12 months
  5. Changes in the dose or number of anti-hypertensive, lipid-lowering, or diabetic medications over the past 3 months prior to randomization
  6. Does not own a smartphone or tablet
  7. Unable or unwilling to abstain from pistachio intake for 6 months
  8. Unable or unwilling to limit nut consumption to ≤1 serving/week for 6 months
  9. Unable or unwilling to complete online questionnaires and cognitive assessments
  10. Unable or unwilling to travel to a local Quest site for biospecimen collection
  11. Unable or unwilling to provide consent to participate in the trial
  12. Failure to complete the baseline Life Satisfaction Questionnaire
  13. Failure to complete the baseline cognitive assessments
  14. Failure to complete the baseline biospecimen collection
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
97 participants (actual)

Study arms

  • Active comparator
    Pistachio-enriched diet

    1 packet/day of approximately 1.25 oz (35 g) of dry roasted, unsalted, shelled pistachio kernels

    Other: Pistachio-enriched diet

  • Other
    Usual diet

    Usual diet (while abstaining from pistachio consumption and limiting other nut consumption to ≤1 serving/week)

    Other: Usual diet

Interventions

  • OtherPistachio-enriched diet

    1 packet/day of approximately 1.25 oz (35 g) of dry roasted, unsalted, shelled pistachio kernels

  • OtherUsual diet

    Usual diet (while abstaining from pistachio consumption and limiting other nut consumption to ≤1 serving/week)

06

What researchers measure

Primary outcomes

  1. Mobile Toolbox

    The investigators will assess 6-month changes in the Mobile Toolbox (MTB) fluid cognition composite (FCC) score via MyCap. Participants will be instructed to install the MyCap app on their personal smartphones to complete the assessments. The FCC score considers the following domains (tests): associative memory (Face and Names), episodic memory (Arranging Pictures), working memory (Sequences), processing speed (Number-Symbol Match), and executive function (Arrow Matching for inhibitory control, Shape-Color Sorting for cognitive flexibility). The FCC score will be calculated by standardizing scores for each MTB test using means and standard deviations (SD) across the entire sample and averaging z-scores across the six tests (mean=0; SD=1). Higher FCC scores will indicate better cognitive function.

    Time frame: Baseline and 6 months

Secondary outcomes

  1. Blood pressure

    The investigators will assess 6-month changes in seated systolic and diastolic blood pressure (in mmHg).

    Time frame: Baseline and 6 months

  2. Life Satisfaction for the Third Age-Short Form

    The investigators will assess 6-month changes in total score for the "Life Satisfaction for the Third Age-Short Form" questionnaire, a validated self-rated 12-item assessment of successful aging and psychological well-being among older adults. Participants will be instructed to select an answer that most closely reflect their attitude towards each statement on a Likert scale from 1 (strongly disagree) to 6 (strongly agree). Scores may range from 6-72, in which a higher score indicates greater life satisfaction.

    Time frame: Baseline and 6 months

  3. Shape-Color Sorting

    The investigators will assess 6-month changes in the Mobile Toolbox "Shape-Color Sorting" test as a measure of cognitive flexibility, a component of executive function (individual cognitive domain). Participants are primary scored on rate correct per second, using the number of correct trials per second as a derived score. Raw rate scores may range from 0-10, in which a higher score indicates better cognitive flexibility.

    Time frame: Baseline and 6 months

  4. Arrow Matching

    The investigators will assess 6-month changes in the Mobile Toolbox "Arrow Matching" test as a measure of inhibitory control, a component of executive function (individual cognitive domain). Participants are primary scored on rate correct per second, using the number of correct trials per second as a derived score. Raw rate scores may range from 0-10, in which a higher score indicates better inhibitory control.

    Time frame: Baseline and 6 months

  5. Faces and Names

    The investigators will assess 6-month changes in the Mobile Toolbox "Faces and Names" test as a measure of associative memory (individual cognitive domain). The test consists of one encoding phase and three memory phases: Face Recognition, Name Recall, and Name Recognition (possible score range for each: 0-12). Total raw scores may range from 0-36, in which a higher score indicates better associative memory.

    Time frame: Baseline and 6 months

  6. Body weight

    The investigators will assess 6-month changes in body weight (in kg).

    Time frame: Baseline and 6 months

  7. Lipid profile

    The investigators will assess 6-month changes in lipid profiles, including total cholesterol, low-density lipoprotein cholesterol (Friedewald calculated), high-density lipoprotein cholesterol, and triglycerides. All lipids will be reported as mg/dL.

    Time frame: Baseline and 6 months

  8. Fasting blood glucose

    The investigators will assess 6-month changes in fasting blood glucose (in mg/dL).

    Time frame: Baseline and 6 months

  9. Insulin-like growth factor-1

    The investigators will assess 6-month changes of insulin-like growth factor-1 in the blood (in ng/mL).

    Time frame: Baseline and 6 months

  10. Interleukin-6

    The investigators will assess 6-month changes of interleukin-6 in the blood (in pg/mL).

    Time frame: Baseline and 6 months

  11. Arranging Pictures

    The investigators will assess 6-month changes in the Mobile Toolbox "Arranging Pictures" test as a measure of episodic memory (individual cognitive domain). This test scores the sum of adjacent pairs correctly placed across two trials. Raw scores range from 0-26 (14 images results in a maximum of 13 adjacent pairs correct per trial), in which a higher score indicates better episodic memory.

    Time frame: Baseline and 6 months

  12. Sequences

    The investigators will assess 6-month changes in the Mobile Toolbox "Sequences" test as a measure of working memory (individual cognitive domain). This score is the total number of items (individual sequence) correctly answered. The possible raw score range is 0-30, in which a higher score indicates better working memory.

    Time frame: Baseline and 6 months

  13. Number-Symbol Match

    The investigators will assess 6-month changes in the Mobile Toolbox "Number-Symbol Match" test as a measure of processing speed (individual cognitive domain). The test includes 144 total items, with up to 16 successive screens of 9 items each presented, and examinees have 90 seconds to complete as many items as possible. This score is the total number of items correctly answered in 90 seconds. The possible raw score range is 0-144, in which a higher score indicates better processing speed.

    Time frame: Baseline and 6 months

  14. Waist circumference

    The investigators will assess 6-month changes in waist circumference (in cm).

    Time frame: Baseline and 6 months

Other outcomes

  1. Lutein

    The investigators will assess 6-month changes in serum lutein (in µmol/L) as a marker of compliance with pistachio consumption. Participants in the pistachio group are expected to have increases in serum lutein levels, while participants in the usual group are expected to have no changes.

    Time frame: Baseline and 6 months

  2. Gamma tocopherol

    The investigators will assess 6-month changes in serum gamma tocopherol (mg/L) as a marker of compliance with pistachio consumption. Participants in the pistachio group are expected to have increases in serum gamma tocopherol levels, while participants in the usual group are expected to have no changes.

    Time frame: Baseline and 6 months

07

Study locations

1 site
08

References and documents

Publications

  • Park SJ, Gavilan IS, Li S, Clar A, Lau J, Karbowski GC, Sarkissian AA, Camara M, Sesso HD. Effects of pistachio consumption on cognition, cardiometabolic risk factors, and life satisfaction in older adults: Protocol for a remote-based randomized controlled trial. Contemp Clin Trials. 2026 Jun;165:108316. doi: 10.1016/j.cct.2026.108316. Epub 2026 Apr 15. PubMed 41991057 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Mar 2027, 22 months after the start.

Of 250 non-industry interventional studies with no phase under Personal Satisfaction, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 21. This study's planned 22 months is above that.

Counting every sponsor, half of 257 studies reached it within 9 months; a quarter within 3 and three quarters within 21.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 3, 2026: primary completion Nov 2026 → Mar 2027 and completion Nov 2026 → Mar 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 29, 2025
First posted
May 28, 2025
StartActual
May 28, 2025
Primary completionEst.
Mar 2027was Nov 2026
CompletionEst.
Mar 2027was Nov 2026
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Nov 2026→Mar 2027
Nov 3, 2026
Study completion
Nov 2026→Mar 2027
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    Primary completion Nov 2026→Mar 2027
    Study completion Nov 2026→Mar 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06992544
Collaborators
American Pistachio Growers, Boston Children's Hospital, Boston, MA, USA, University of Illinois at Urbana-Champaign, Quest Diagnostics-Nichols Insitute
Responsible party
Howard D. Sesso, ScD, MPH (Associate Epidemiologist, Brigham and Women's Hospital) — Principal investigator
First posted
May 28, 2025
Start date
May 28, 2025
Primary completion
Mar 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Nov 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion